Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome

(European Society of Cardiology) The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound study reveal.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news